YS Biopharma Management
Management criteria checks 0/4
YS Biopharma's CEO is David Shao, appointed in Mar 2023, has a tenure of 1.17 years. directly owns 1.09% of the company’s shares, worth $1.58M. The average tenure of the management team and the board of directors is 1.2 years and 0.3 years respectively.
Key information
David Shao
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 1.2yrs |
CEO ownership | 1.1% |
Management average tenure | 1.2yrs |
Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
David Shao (55 yo)
1.2yrs
Tenure
Dr. Hui Shao, also known as David, Ph D served as Senior Vice President of Finance at China Aoxing Pharmaceutical Co. Inc. from January 4, 2007 to 2010. Dr. Shao was responsible for all its financial and a...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Head of Marketing & Sales | 1.2yrs | no data | no data | |
Head of Vaccine Research | 1.2yrs | no data | no data | |
President | 1.2yrs | no data | 1.09% CN¥ 1.6m | |
Chief Financial Officer & Director | less than a year | no data | 0.052% CN¥ 75.3k | |
Chief Medical Officer | 1.2yrs | no data | no data |
1.2yrs
Average Tenure
45yo
Average Age
Experienced Management: YS's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 1.2yrs | no data | 1.09% CN¥ 1.6m | |
Chief Financial Officer & Director | less than a year | no data | 0.052% CN¥ 75.3k | |
Independent Director | 1.2yrs | no data | 0.038% CN¥ 56.0k | |
Independent Chairman | 1.2yrs | no data | 0.046% CN¥ 66.6k | |
Independent Director | less than a year | no data | no data | |
Director | less than a year | no data | no data | |
Director | less than a year | no data | no data | |
Director | less than a year | no data | no data | |
Director | less than a year | no data | no data | |
Director | less than a year | no data | no data |
0.3yrs
Average Tenure
55yo
Average Age
Experienced Board: YS's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.